Hansoh Pharmaceutical Group Company Limited (HKG: 3692)

Hansoh Pharmaceutical Group Company Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	101,358	93,358	87,864	112,525	222,554	149,925
Market Cap Growth	29.43%	6.25%	-21.92%	-49.44%	48.44%	-
Enterprise Value	76,239	72,847	68,167	95,387	204,073	135,460
Last Close Price	17.08	15.47	14.41	18.26	36.05	24.83
PE Ratio	20.97	26.88	29.19	33.62	69.44	47.56
Forward PE	23.50	28.31	24.97	27.09	54.85	43.34
PS Ratio	7.79	8.39	8.28	9.23	21.56	15.44
PB Ratio	3.38	3.29	3.43	4.58	10.48	10.27
P/TBV Ratio	3.25	3.31	3.44	4.58	10.49	10.28
P/FCF Ratio	21.32	29.25	31.49	43.30	194.63	48.96
P/OCF Ratio	19.34	27.19	28.35	35.57	78.39	40.25
PEG Ratio	3.54	3.12	1.56	1.11	1.97	1.80
EV/Sales Ratio	5.86	6.54	6.43	7.82	19.77	13.95
EV/EBITDA Ratio	15.29	21.86	20.57	25.20	57.48	40.85
EV/EBIT Ratio	16.73	24.68	23.13	27.55	61.97	43.55
EV/FCF Ratio	16.04	22.83	24.43	36.71	178.47	44.24
Debt / Equity Ratio	0.00	0.17	0.19	0.19	0.01	0.00
Debt / EBITDA Ratio	0.03	1.41	1.48	1.24	0.03	0.00
Debt / FCF Ratio	0.03	1.49	1.77	1.81	0.10	0.00
Asset Turnover	0.38	0.32	0.33	0.41	0.43	0.62
Inventory Turnover	1.81	2.02	2.03	2.46	2.25	1.65
Quick Ratio	7.70	4.11	9.64	7.50	6.30	2.70
Current Ratio	7.98	4.21	9.86	7.67	6.43	2.80
Return on Equity (ROE)	18.10%	13.53%	12.11%	14.31%	16.62%	32.96%
Return on Assets (ROA)	8.33%	5.31%	5.70%	7.35%	8.59%	12.42%
Return on Capital (ROIC)	9.34%	5.86%	6.41%	8.43%	11.17%	22.39%
Earnings Yield	5.24%	3.87%	3.32%	2.96%	1.37%	1.91%
FCF Yield	4.92%	3.42%	3.18%	2.31%	0.51%	2.04%
Dividend Yield	2.33%	1.38%	0.69%	0.49%	0.21%	-
Payout Ratio	13.83%	19.90%	27.56%	14.04%	163.49%	58.67%
Buyback Yield / Dilution	-1.34%	-1.52%	1.14%	-2.04%	-7.31%	-9.55%
Total Shareholder Return	0.99%	-0.14%	1.83%	-1.55%	-7.10%	-9.55%

Source: S&P Capital IQ. Standard template. Financial Sources.